Pharmena S.A. is a biotechnology company that specializes in the development and production of innovative products based on its proprietary active ingredient, 1-MNA (1-methylnicotinamide). The company's primary focus is on skincare and dermatological products, leveraging its scientific research to create solutions that promote skin health and address various dermatological conditions. Pharmena S.A.'s portfolio includes a range of topical applications aimed at enhancing skin regeneration and protection. Operating in the pharmaceutical and nutraceutical sectors, the company also explores the potential of 1-MNA in the prevention and treatment of lifestyle-related diseases, contributing to the expanding field of preventive healthcare. By integrating rigorous scientific methodologies and clinical evaluations, Pharmena S.A. maintains a significant presence in the biotechnology industry, emphasizing innovation and evidence-based product development. This focus underpins its role in enhancing consumer health and wellbeing while marking its influence on the evolving landscape of health-focused biotechnology solutions.